Adaptimmune Therapeutics Plc Cash Flow Reinvestment Rate
Adaptimmune Therapeutics Plc cash flow reinvestment rate. Adaptimmune Therapeutics Plc (ADAP) has a Cash Flow Reinvestment Rate of 0.03x as of June 2024, reinvesting $1.50 Million (capex $754.55K plus investments $-743.00K) from operating cash flow of $47.39 Million. Explore cash flow to debt ratio of Adaptimmune Therapeutics Plc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Adaptimmune Therapeutics Plc (2013–2021)
Cash flow reinvestment rate of Adaptimmune Therapeutics Plc from 2013 to 2021. Historical reinvestment intensity for Adaptimmune Therapeutics Plc across 2 annual periods. Explore reinvestment intensity of Adaptimmune Therapeutics Plc to see what proportion of operating cash flow is directed to capital expenditures.
Adaptimmune Therapeutics Plc Cash Flow Reinvestment Rate by Year (2013–2021)
Adaptimmune Therapeutics Plc cash flow reinvestment rate by year from 2013 to 2021. Year-by-year capital reinvestment analysis for Adaptimmune Therapeutics Plc. For the full cash flow conversion analysis, see Adaptimmune Therapeutics Plc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 8.70x | $93.36 Million | $10.73 Million | $8.78 Million | ▲ +485.6% |
| 2013 | 1.49x | $55.33 Million | $37.23 Million | $1.45 Million | — |